Press Releases

TORONTO, June 18, 2024 /PRNewswire/ - Henrique Bilbao, Vice President of Internationalization at ACATE - Technology Association of Santa Catarina State, Brazil, Peter Hawkins, Co-Chair at Brazil-Canada Chamber of Commerce (BCCC) and their delegates joined Guillaume Legare, Head South America, Toronto Stock Exchange to close the market.

ACATE is an association that brings together over 1,700 technology companies and institutions from the... (continue reading...)

• Cathedra has secured conditional approval from the TSX-V for its previously announced merger with Kungsleden, Inc., a developer and operator of alternative high-density compute infrastructure

• The original share exchange agreement has been amended, increasing Cathedra's ownership in the pro forma company from 22.5% to 27.5%, implying a C$19.2 million reduction in total consideration paid to Kungsleden shareholders in the merger

• A meeting of Cathedra shareholders to approve... (continue reading...)

MONTREAL, June 18, 2024 (GLOBE NEWSWIRE) -- Yorbeau Resources Inc. (TSX: YRB) (“Yorbeau” or the “Company”) announces that the nominees listed in the Company’s management proxy circular dated May 17, 2024 were elected as directors of Yorbeau. The detailed results of the vote for the election of directors held at the annual general meeting of shareholders on June 18, 2024 in Montreal are set out below.

Company to exceed Q2 revenue guidance and maintains Adjusted EBITDA outlook

CHARLOTTE, N.C., June 18, 2024 /PRNewswire/ -- LendingTree, Inc. (NASDAQ: TREE), is the parent of LendingTree, LLC and several companies owned by LendingTree, LLC (collectively, "LendingTree" or the "Company") and the operator of LendingTree.com, the nation's leading online financial services marketplace, announces the promotion of Jason Bengel to Chief Financial Officer following the... (continue reading...)

SAN DIEGO and TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced the voting results from the Company’s annual and special meeting of shareholders held today, June 18, 2024 (the “Meeting”). A total of 8,101,527 common shares of the Company,... (continue reading...)